676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)
Saved in:
| Title: | 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2) |
|---|---|
| Authors: | Lodise, Thomas1 (AUTHOR), Colman, Sam2 (AUTHOR), Alexander, Elizabeth3 (AUTHOR), Stein, Daniel3 (AUTHOR), Fitts, David3 (AUTHOR), Goldberg, Lisa3 (AUTHOR), Schranz, Jennifer3 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS308-S309. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 139394976 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2) – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lodise%2C+Thomas%22">Lodise, Thomas</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colman%2C+Sam%22">Colman, Sam</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alexander%2C+Elizabeth%22">Alexander, Elizabeth</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stein%2C+Daniel%22">Stein, Daniel</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fitts%2C+David%22">Fitts, David</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goldberg%2C+Lisa%22">Goldberg, Lisa</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schranz%2C+Jennifer%22">Schranz, Jennifer</searchLink><relatesTo>3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Open+Forum+Infectious+Diseases%22">Open Forum Infectious Diseases</searchLink>. 2019 Supplement, Vol. 6, pS308-S309. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=139394976 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ofid/ofz360.744 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S308 Titles: – TitleFull: 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2) Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lodise, Thomas – PersonEntity: Name: NameFull: Colman, Sam – PersonEntity: Name: NameFull: Alexander, Elizabeth – PersonEntity: Name: NameFull: Stein, Daniel – PersonEntity: Name: NameFull: Fitts, David – PersonEntity: Name: NameFull: Goldberg, Lisa – PersonEntity: Name: NameFull: Schranz, Jennifer IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2019 Supplement Type: published Y: 2019 Identifiers: – Type: issn-print Value: 23288957 Numbering: – Type: volume Value: 6 Titles: – TitleFull: Open Forum Infectious Diseases Type: main |
| ResultId | 1 |